Chemesis International (CSE:CSI, OTC:CADMF, FWB:CWAA) CEO Edgar Montero discussed the company’s agreement with First Medical Cannabis LLC in an interview with Midas Letter Live. Chemesis is a licensed producer and manufacturer of medical and recreational cannabis with operations in California, Puerto Rico and Colombia. The company’s agreement and partnership with First Medical Cannabis provide Chemesis with access to 6,000 acres of agricultural land in Puerto Rico. Montero believes that the deal has the potential to expand not only the cannabis industry in Puerto Rico, but the entire island along with it.

“After the Hurricane Maria, I don’t know if you were aware, but last September 2017, we were struck by this Category 5 hurricane, and trying to fix from the roads the electric grid. The entire island has been a challenge for Puerto Ricans, and I believe a project like this one will bring certainty to the industry, first and foremost; will bring a lot of jobs to the community, and we’re trying to put our best effort to try to develop something that is meaningful not only for cannabis, not only for our company but for the people in Puerto Rico,” said Montero.

Montero also discussed the challenges of importing cannabis into the US and how the company is positioning itself to become a dominant international player. He also provided an update on the company’s Colombia assets along with an overview of what’s next to come for Chemesis.

“Obviously we’re trying to do other business in other jurisdictions in the US, so I think that this year, Chemesis will continue with its expansion, the credibility of course, and bringing more people into our company,” said Montero.

To read the full interview, click here.

Click here to connect with Chemesis International Inc. (CSE:CSI, OTC:CADMF) for an Investor Presentation. 

CANBUD Distribution Corp. (CSE:CBDX, FSE:CD0) leverages on timely and methodical execution of its revenue generating plan. It operates a trinitarian enterprise model in the plant-based protein, psychedelic pharmaceutical and non-psychedelic nutraceutical, and hemp cannabinoids (CBD) spaces. (

Keep reading... Show less


Keep reading... Show less

Market entry will address pent-up demand in the Japanese & Philippine markets for TRACE proprietary plant-based mineral formulation and wellness-focused products

Emerging leader in innovative health and wellness beverages and natural products, BevCanna Enterprises Inc. ( CSE:BEV , Q:BVNNF , FSE:7BC ) (“ BevCanna ” or the “ Company ”) announces today that has entered into an exclusive sales agency distribution agreement with Yokohama-based Mirai Marketing Inc. (“Mirai”) to bring Naturo Group’s TRACE proprietary plant-based mineral consumer products to Mirai’s extensive Japanese and Philippine sales and distribution networks.

Keep reading... Show less

Further to its press release dated April 12, 2021, Ayurcann Holdings Corp. ( CSE: AYUR ) (the “ Company ” or “ Ayurcann ”), is pleased to announce that it has oversubscribed and upsized its non-brokered private placement (the “Offering”) due to strong investor demand. The Company now anticipates that the Offering will be completed for gross proceeds of not less than $550,000.00, consisting of not less than 2,910,053 units (“Units”) at a price of $0.189 per Unit. Each Unit is comprised of one common share of the Company (a “Common Share”) and one half of one Common Share purchase warrant (a “Warrant”). Each Warrant is exercisable to acquire one Common Share at an exercise price of C$0.38 per Common Share for a period of 36 months from the date of closing of the Offering (the “Closing Date”), scheduled for April 22, 2021. The Units will have a hold period of four months and one day from the date of issuance.

Ayurcann CEO Igal Sudman commented: “We are very pleased with the demand we are seeing for the Offering. The feedback we have received to date is showing that our business is resonating with investors. We’re looking forward to closing the offering and proceeding with the planned Phase 2 build out, which will help greatly increase our facility’s capacity.”

Keep reading... Show less

UK InstaCoin APP Promises to Open NFTs up to the Masses through Social Media

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) is pleased to provide an update on its recent investment in InstaCoin Technologies Ltd., a newly formed UK entity

Keep reading... Show less